Base Editor Scanning Reveals Activating Mutations of DNMT3A

被引:4
|
作者
Garcia, Emma M. [1 ,2 ]
Lue, Nicholas Z. [1 ,2 ]
Liang, Jessica K. [1 ]
Lieberman, Whitney K. [1 ]
Hwang, Derek D. [1 ]
Woods, James C. [1 ,2 ]
Liau, Brian B. [1 ,2 ]
机构
[1] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA
[2] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
VARIANTS; METHYLATION;
D O I
10.1021/acschembio.3c00257
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DNAmethyltransferase 3A (DNMT3A) is a de novo cytosinemethyltransferase responsible for establishing proper DNAmethylation during mammalian development. Loss-of-function (LOF) mutationsto DNMT3A, including the hotspot mutation R882H, frequently occurin developmental growth disorders and hematological diseases, includingclonal hematopoiesis and acute myeloid leukemia. Accordingly, identifyingmechanisms that activate DNMT3A is of both fundamental and therapeuticinterest. Here, we applied a base editor mutational scanning strategywith an improved DNA methylation reporter to systematically identifyDNMT3A activating mutations in cells. By integrating an optimizedcellular recruitment strategy with paired isogenic cell lines withor without the LOF hotspot R882H mutation, we identify and validatethree distinct hyperactivating mutations within or interacting withthe regulatory ADD domain of DNMT3A, nominating these regions as potentialfunctional target sites for pharmacological intervention. Notably,these mutations are still activating in the context of a heterozygousR882H mutation. Altogether, we showcase the utility of base editorscanning for discovering functional regions of target proteins.
引用
收藏
页码:2030 / 2038
页数:9
相关论文
共 50 条
  • [31] DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia
    Ferreira, H. J.
    Heyn, H.
    Vizoso, M.
    Moutinho, C.
    Vidal, E.
    Gomez, A.
    Martinez-Cardus, A.
    Simo-Riudalbas, L.
    Moran, S.
    Jost, E.
    Esteller, M.
    ONCOGENE, 2016, 35 (23) : 3079 - 3082
  • [32] Regulation of Human RNA Polymerase III Transcription by DNMT1 and DNMT3a DNA Methyltransferases
    Selvakumar, Tharakeswari
    Gjidoda, Alison
    Hovde, Stacy L.
    Henry, R. William
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (10) : 7039 - 7050
  • [33] Insight into the selective binding mechanism of DNMT1 and DNMT3A inhibitors: a molecular simulation study
    Xie, Tianli
    Yu, Jie
    Fu, Weitao
    Wang, Zhe
    Xu, Lei
    Chang, Shan
    Wang, Ercheng
    Zhu, Feng
    Zeng, Su
    Kang, Yu
    Hou, Tingjun
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2019, 21 (24) : 12931 - 12947
  • [34] DNA Methyltransferase Expression (DNMT1, DNMT3a, and DNMT3b) as a Potential Biomarker in Age-Related Macular Degeneration
    Camacho, Pedro
    Ribeiro, Edna
    Pereira, Bruno
    Nascimento, Joao
    Caldeira Rosa, Paulo
    Henriques, Jose
    Barrao, Sandra
    Sadio, Silvia
    Quendera, Bruno
    Delgadinho, Mariana
    Ginete, Catarina
    Silva, Carina
    Brito, Miguel
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)
  • [35] The DNMT3A R882H mutation does not cause dominant negative effects in purified mixed DNMT3A/R882H complexes
    Emperle, Max
    Dukatz, Michael
    Kunert, Stefan
    Holzer, Katharina
    Rajavelu, Arumugam
    Jurkowska, Renata Z.
    Jeltsch, Albert
    SCIENTIFIC REPORTS, 2018, 8
  • [36] Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients
    Yuan, Xiao-Qing
    Zhang, Dao-Yu
    Yan, Han
    Yang, Yong-Long
    Zhu, Ke-Wei
    Chen, Yan-Hong
    Li, Xi
    Yin, Ji-Ye
    Li, Xiao-Lin
    Zeng, Hui
    Chen, Xiao-Ping
    ONCOTARGET, 2016, 7 (37) : 60555 - 60574
  • [37] DNMT3a expression pattern and its prognostic value in lung adenocarcinoma
    Husni, Ryan Edbert
    Shiba-Ishii, Aya
    Iiyama, Shinji
    Shiozawa, Toshihiro
    Kim, Yunjung
    Nakagawa, Tomoki
    Sato, Taiki
    Kano, Junko
    Minami, Yuko
    Noguchi, Masayuki
    LUNG CANCER, 2016, 97 : 59 - 65
  • [38] DNA methylation and hydroxymethylation patterns in acute myeloid leukemia patients with mutations in DNMT3A and IDH1/2 and their combinations
    Sestakova, Sarka
    Krejcik, Zdenek
    Folta, Adam
    Cerovska, Ela
    Salek, Cyril
    Merkerova, Michaela Dostalova
    Pecherkova, Pavla
    Racil, Zdenek
    Mayer, Jiri
    Cetkovsky, Petr
    Remasova, Hana
    CANCER BIOMARKERS, 2019, 25 (01) : 43 - 51
  • [39] DNMT3A R882 Mutations Predict a Poor Prognosis in AML A Meta-Analysis From 4474 Patients
    Yuan, Xiao-Qing
    Peng, Li
    Zeng, Wen-Jing
    Jiang, Bin-Yuan
    Li, Guan-Cheng
    Chen, Xiao-Ping
    MEDICINE, 2016, 95 (18) : e3519
  • [40] Graft-versus-host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations
    Newell, Laura F.
    Dunlap, Jennifer
    Gatter, Ken
    Bagby, Grover C.
    Press, Richard D.
    Cook, Rachel J.
    Fletcher, Luke
    Leonard, Jessica T.
    Leong, Kelli M.
    Bubalo, Joseph S.
    Olyaei, Ali
    Deloughery, Thomas G.
    Maziarz, Richard T.
    Maynard, Erin
    Orloff, Susan L.
    Kristian Enestvedt, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (12) : 3894 - 3906